{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:34:45Z","timestamp":1784914485159,"version":"3.55.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.cld.2008.02.013","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T10:00:23Z","timestamp":1210327223000},"page":"385-406","source":"Crossref","is-referenced-by-count":48,"title":["Pruritus in Primary Biliary Cirrhosis: Pathogenesis and Therapy"],"prefix":"10.1016","volume":"12","author":[{"given":"Nora V.","family":"Bergasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2008.02.013_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2340\/00015555-0350","article-title":"Itch in primary biliary cirrhosis: a patients' perspective","volume":"88","author":"Rishe","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cld.2008.02.013_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007180","article-title":"The clinical expression of primary biliary cirrhosis","volume":"17","author":"Heathcote","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.013_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001090050246","article-title":"The human mu opioid receptor gene: 5' regulatory and intronic sequences","volume":"76","author":"Wendel","year":"1998","journal-title":"J Mol Med"},{"key":"10.1016\/j.cld.2008.02.013_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/dmd.31.5.677","article-title":"Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy","volume":"31","author":"Hirota","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cld.2008.02.013_bib5","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2008.02.013_bib6","doi-asserted-by":"crossref","unstructured":"Lin Xiang Wei, Floriani A, Variola A, et\u00a0al. A Study of the mu opioid receptor gene polymorphism A 118G in patients with primary biliary cirrhosis with and without pruritus. Acta Derm Venereol 2008, in press.","DOI":"10.2340\/00015555-0436"},{"key":"10.1016\/j.cld.2008.02.013_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/hep.21165","article-title":"A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus","volume":"43","author":"Floreani","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib8","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/gut.52.12.1788","article-title":"ABC of oral bioavailability: transporters as gatekeepers in the gut","volume":"52","author":"Dietrich","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.013_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.cld.2008.02.013_bib10","first-page":"787","article-title":"Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2","volume":"378","author":"Keppler","year":"1997","journal-title":"Biol Chem"},{"key":"10.1016\/j.cld.2008.02.013_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/dmd.104.001420","article-title":"Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5]enkephalin","volume":"33","author":"Hoffmaster","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cld.2008.02.013_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2005.12.012","article-title":"Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure","volume":"44","author":"Newton","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.013_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","article-title":"Natural history of pruritus in primary biliary cirrhosis","volume":"1","author":"Talwalkar","year":"2003","journal-title":"J Clinical Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bmj.2.4797.1289","article-title":"Testosterone therapy for the pruritus of obstructive jaundice","volume":"2","author":"Lloyd-Thomas","year":"1952","journal-title":"Br Med J"},{"key":"10.1016\/j.cld.2008.02.013_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(96)04328-0","article-title":"Pathophysiology of itching","volume":"348","author":"Greaves","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.013_bib18","first-page":"400","article-title":"Application of piezo film technology for the quantitative assessment of pruritus","volume":"25","author":"Talbot","year":"1991","journal-title":"Biomed Instrum Technol"},{"key":"10.1016\/j.cld.2008.02.013_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1515\/bmte.1996.41.9.248","volume":"41","author":"Stein","year":"1996","journal-title":"Biomed Tech (Berl)"},{"key":"10.1016\/j.cld.2008.02.013_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02510746","article-title":"Improved device for measuring scratching activity in patients with pruritus","volume":"36","author":"Molenaar","year":"1998","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.cld.2008.02.013_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/bmte.2001.46.5.137","article-title":"Pruritometer 2: portable recording system for the quantification of scratching as objective criterion for the pruritus","volume":"46","author":"Bijak","year":"2001","journal-title":"Biomed Tech (Berl)"},{"key":"10.1016\/j.cld.2008.02.013_bib22","series-title":"The liver: biology and pathobilogy","first-page":"1105","article-title":"Cholestasis","author":"Reichen","year":"1988"},{"key":"10.1016\/j.cld.2008.02.013_bib23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2008.02.013_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","article-title":"Open-label trial of oral nalmefene therapy for the pruritus of cholestasis","volume":"27","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.013_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0676.1996.tb00749.x","article-title":"Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis","volume":"16","author":"Bergasa","year":"1996","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.013_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1034\/j.1600-0676.2002.01458.x","article-title":"Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis","volume":"22","author":"Bergasa","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.013_bib30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0016-5085(92)90857-U","article-title":"Endogenous opioids accumulate in plasma in a rat model of acute cholestasis","volume":"103","author":"Swain","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib31","first-page":"2028","article-title":"Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis","volume":"89","author":"Spivey","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-8278(05)80471-4","article-title":"Cholestasis in the male rat is associated with naloxone-reversible antinociception","volume":"20","author":"Bergasa","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.6171882","article-title":"Sensory and motor functions of spinal cord substance P","volume":"214","author":"Piercey","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.cld.2008.02.013_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","article-title":"Scratching behavior induced by pruritogenic but not algesiogenic agents in mice","volume":"275","author":"Kuraishi","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cld.2008.02.013_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pain.2005.04.014","article-title":"Role of NK-1 neurotransmission in opioid-induced hyperalgesia","volume":"116","author":"King","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.cld.2008.02.013_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bip.20254","article-title":"Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure","volume":"80","author":"Ossipov","year":"2005","journal-title":"Biopolymers"},{"key":"10.1016\/j.cld.2008.02.013_bib37","article-title":"Serum concentrations of Substance P are increased in cholestasis: potential clinical implications","volume":"130","author":"Trivedi","year":"2005","journal-title":"Gastroenterology (Supplement)"},{"key":"10.1016\/j.cld.2008.02.013_bib38","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199405263302117","article-title":"Ondansetron for pruritus due to cholestasis","volume":"21","author":"Raderer","year":"1994","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.cld.2008.02.013_bib39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0140-6736(93)91178-O","article-title":"Improvement of cholestatic pruritus by ondansetron","volume":"341","author":"Schworer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.013_bib40","first-page":"A1349","article-title":"Ondansetron in the treatment of the pruritus of cholestasis: a randomised controlled trial","volume":"112","author":"O'Donohue","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib41","first-page":"1196","article-title":"Ondansetron and pruritus in chronic liver disease: a controlled study","volume":"54","author":"Jones","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02430.x","article-title":"A controlled trial of ondansetron in the pruritus of cholestasis","volume":"21","author":"O'Donohue","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.02.013_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"Muller","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3959(94)00145-5","article-title":"Relief of cholestatic pruritus by a novel class of drugs: 5- hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron","volume":"61","author":"Schworer","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.cld.2008.02.013_bib45","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","article-title":"Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis","volume":"98","author":"Browning","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1749-6632.1990.tb16906.x","article-title":"Serotonin and nociception","volume":"600","author":"Richardson","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cld.2008.02.013_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/00015550152572868","article-title":"Scratch induction in the rat by intradermal serotonin: a model for pruritus","volume":"81","author":"Thomsen","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cld.2008.02.013_bib49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0270(03)00074-8","article-title":"Quantitative assessment of directed hind limb scratching behavior as a rodent itch model","volume":"126","author":"Nojima","year":"2003","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.cld.2008.02.013_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.510250206","article-title":"Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment","volume":"25","author":"Swain","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/hep.20617","article-title":"Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat","volume":"41","author":"Celik","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib52","first-page":"115","article-title":"Subpopulations of \u201cnocifensor neurons\u201d contributing to pain and allodynia, itch and allokinesis","volume":"1","author":"LaMotte","year":"1992","journal-title":"Am Pain Soc J"},{"key":"10.1016\/j.cld.2008.02.013_bib53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.62.2.212","article-title":"Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch","volume":"62","author":"Ikoma","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cld.2008.02.013_bib54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/01.WNL.0000078193.64949.08","article-title":"Active \u201citch fibers\u201d in chronic pruritus","volume":"61","author":"Schmelz","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cld.2008.02.013_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/82924","article-title":"Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch","volume":"4","author":"Andrew","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cld.2008.02.013_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2006.07.004","article-title":"Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats","volume":"85","author":"Inan","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.cld.2008.02.013_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.102.044909","article-title":"Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys","volume":"305","author":"Ko","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cld.2008.02.013_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.103.061101","article-title":"The role of central mu opioid receptors in opioid-induced itch in primates","volume":"310","author":"Ko","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cld.2008.02.013_bib59","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstrom","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cld.2008.02.013_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","article-title":"A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord","volume":"448","author":"Sun","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cld.2008.02.013_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.06.019","article-title":"Spontaneous scratching behavior in MRL\/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride","volume":"518","author":"Umeuchi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cld.2008.02.013_bib62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.4.5946.693","article-title":"Pruritic effect of bile salts","volume":"4","author":"Kirby","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.cld.2008.02.013_bib63","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archderm.109.5.678","article-title":"Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin","volume":"109","author":"Varadi","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib64","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1023\/A:1018868126743","article-title":"Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis","volume":"43","author":"Ricci","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2008.02.013_bib65","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1152\/jn.1994.72.6.3004","article-title":"Urge to scratch represented in the human cerebral cortex during itch","volume":"72","author":"Hsieh","year":"1994","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.cld.2008.02.013_bib66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(03)00249-5","article-title":"Imaging of central itch modulation in the human brain using positron emission tomography","volume":"105","author":"Mochizuki","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.cld.2008.02.013_bib67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0304-3959(01)00271-8","article-title":"Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies","volume":"92","author":"Drzezga","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.cld.2008.02.013_bib68","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1523-1747.2000.00193.x","article-title":"Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions","volume":"115","author":"Darsow","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib69","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.0022-202X.2005.23817.x","article-title":"Brain activation by histamine prick test-induced itch","volume":"125","author":"Walter","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1152\/jn.00070.2006","article-title":"Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans","volume":"97","author":"Leknes","year":"2007","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.cld.2008.02.013_bib71","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuroimage.2007.04.003","article-title":"Neural correlates of perceptual difference between itching and pain: a human fMRI study","volume":"36","author":"Mochizuki","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.cld.2008.02.013_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.jid.5701002","article-title":"Cerebral processing of histamine-induced itch using short-term alternating temperature modulation\u2014an fMRI study","volume":"128","author":"Valet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib73","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","article-title":"A controlled trial of naloxone infusions for the pruritus of chronic cholestasis","volume":"102","author":"Bergasa","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib74","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib75","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease","volume":"293","author":"de la Fuente-Fernandez","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cld.2008.02.013_bib76","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00000539-200003000-00025","article-title":"The inhibition of epidural morphine-induced pruritus by epidural droperidol","volume":"90","author":"Horta","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cld.2008.02.013_bib77","first-page":"312","article-title":"Inhibition of epidural morphine-induced pruritus by intravenous droperidol. The effect of increasing the doses of morphine and of droperidol","volume":"21","author":"Horta","year":"1996","journal-title":"Reg Anesth"},{"key":"10.1016\/j.cld.2008.02.013_bib78","series-title":"The pharmacological basis of therapeutics","first-page":"399","article-title":"Drugs and the treatment of psychiatric disorders","author":"Baldessarini","year":"1996"},{"key":"10.1016\/j.cld.2008.02.013_bib79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(83)90425-9","article-title":"Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?","volume":"94","author":"Reimann","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cld.2008.02.013_bib80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s002130100839","article-title":"Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference","volume":"157","author":"Andrews","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cld.2008.02.013_bib81","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.1093065","article-title":"Placebo-induced changes in FMRI in the anticipation and experience of pain","volume":"303","author":"Wager","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cld.2008.02.013_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib83","first-page":"541","article-title":"Use of colesevelam hydrochloride (Welchol) as a novel therapeutic agent for the management of refractory pruritus in chronic liver disease","volume":"34","author":"Berg","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib84","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2006.08.008","article-title":"Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis","volume":"45","author":"Pusl","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib85","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.transproceed.2005.02.002","article-title":"Therapy of intractable pruritus with MARS","volume":"37","author":"Acevedo Ribo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2008.02.013_bib86","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1572-0241.2004.30204.x","article-title":"Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis","volume":"99","author":"Pares","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/jlts.2003.50055","article-title":"Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus","volume":"9","author":"Doria","year":"2003","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2008.02.013_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0676.2002.00015.x","article-title":"Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC)","volume":"22","author":"Sturm","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.cld.2008.02.013_bib89","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/00365520600610154","article-title":"Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus)","volume":"41","author":"Rifai","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.21271","article-title":"Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis","volume":"44","author":"Beuers","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib91","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jpedsurg.2007.03.029","article-title":"Partial internal biliary diversion through a cholecystojejunocolonic anastomosis\u2013a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report","volume":"42","author":"Bustorff-Silva","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.cld.2008.02.013_bib92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib93","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00005176-200002000-00011","article-title":"Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis","volume":"30","author":"Ng","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2008.02.013_bib94","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.115.11.1366","article-title":"Relief of intractable pruritus with naloxone","volume":"115","author":"Bernstein","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib95","first-page":"1022","article-title":"Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","volume":"91","author":"Carson","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib96","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib97","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib98","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v12.i7.1125","article-title":"Effect of oral naltrexone on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0016-5085(03)00879-5","article-title":"Pain as a complication of use of opiate antagonists for symptom control in cholestasis","volume":"125","author":"McRae","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0304-3959(88)90140-6","article-title":"Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat","volume":"35","author":"Millan","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.cld.2008.02.013_bib101","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00000542-200105000-00027","article-title":"Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation","volume":"94","author":"Perrot","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cld.2008.02.013_bib102","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.6261330","article-title":"Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes","volume":"212","author":"Willer","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.cld.2008.02.013_bib103","series-title":"The pharmacologic basis of therapeutics","first-page":"521","article-title":"Pasternak: opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.cld.2008.02.013_bib104","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.jid.5700411","article-title":"Meeting report of the 3rd International Workshop for the Study of Itch","volume":"126","author":"Yosipovitch","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib106","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/030006057800600506","article-title":"Double-blind comparison of butorphanol tartrate and meperidine hydrochloride in balanced anaesthesia","volume":"6","author":"Stehling","year":"1978","journal-title":"J Int Med Res"},{"key":"10.1016\/j.cld.2008.02.013_bib107","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.48.5.1156","article-title":"Butorphanol (Stadol): a study in problems of current drug information and control","volume":"48","author":"Fisher","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.cld.2008.02.013_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1355621961000124666","article-title":"The mu opioid receptor: from molecular cloning to functional studies","volume":"1","author":"Yu","year":"1996","journal-title":"Addict Biol"},{"key":"10.1016\/j.cld.2008.02.013_bib109","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/1381612043453027","article-title":"The orvinols and related opioids\u2014high affinity ligands with diverse efficacy profiles","volume":"10","author":"Lewis","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cld.2008.02.013_bib110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(99)00259-7","article-title":"Codeine for pruritus in primary biliary cirrhosis","volume":"353","author":"Zylicz","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.013_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-1241.1994.tb09854.x","article-title":"Buprenorphine and hepatic pruritus","volume":"48","author":"Juby","year":"1994","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.cld.2008.02.013_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpainsymman.2007.08.001","article-title":"Transdermal buprenorphine may be effective in the treatment of pruritus in primary biliary cirrhosis","volume":"34","author":"Reddy","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.cld.2008.02.013_bib113","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2141.2001.03161.x","article-title":"Pruritus in polycythaemia vera: prevalence, laboratory correlates and management","volume":"115","author":"Diehn","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cld.2008.02.013_bib114","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.cld.2008.02.013_bib115","first-page":"121","article-title":"Paroxetine for pruritus in advanced cancer","volume":"16","author":"Zylicz","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.cld.2008.02.013_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0447.1997.tb05956.x","article-title":"Mirtazapine: pharmacology in relation to adverse effects","volume":"391","author":"Nutt","year":"1997","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.cld.2008.02.013_bib117","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.cld.2008.02.013_bib118","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2004.01.045","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study","volume":"50","author":"Hundley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib119","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00544371","article-title":"Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis","volume":"28","author":"Hoensch","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cld.2008.02.013_bib120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cld.2008.02.013_bib121","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib122","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib123","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.013_bib124","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpgasthep0746","article-title":"Is rifampin a safe and effective treatment for pruritus caused by chronic cholestasis?","volume":"4","author":"Heathcote","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2008.02.013_bib126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365529209095978","article-title":"Primary biliary cirrhosis: new therapeutic directions","volume":"192","author":"Berg","year":"1992","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.cld.2008.02.013_bib127","series-title":"Diseases of the liver and biliary system","first-page":"236","article-title":"Primary biliary cirrhosis","author":"Sherlock","year":"1991"},{"key":"10.1016\/j.cld.2008.02.013_bib128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2036.1994.tb00297.x","article-title":"Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis","volume":"8","author":"Turner","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2008.02.013_bib129","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1440-1746.1999.01968.x","article-title":"Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study","volume":"14","author":"Watson","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.013_bib130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-82-3-310","article-title":"Phenobarbital effects in cholestatic liver diseases","volume":"82","author":"Bloomer","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.013_bib131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(78)80625-8","article-title":"Efficacy and safety of long-term phenobarbital therapy of familial cholestasis","volume":"93","author":"Ghent","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.cld.2008.02.013_bib132","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.013_bib133","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.296.6622.607","article-title":"Effect of stanozolol on itching in primary biliary cirrhosis","volume":"296","author":"Walt","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.cld.2008.02.013_bib134","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.013_bib135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2005.06498.x","article-title":"Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis","volume":"152","author":"Aguilar-Bernier","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cld.2008.02.013_bib136","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00015550310022899","article-title":"Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres","volume":"84","author":"Wallengren","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cld.2008.02.013_bib137","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1572-0241.2001.03778.x","article-title":"Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease","volume":"96","author":"Bergasa","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib138","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0016-5085(90)91250-A","article-title":"Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study","volume":"99","author":"Frezza","year":"1990","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2008.02.013_bib139","first-page":"122","article-title":"S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial","volume":"139","author":"Frezza","year":"1990","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-125-8-199610150-00032","article-title":"Pruritus associated with cholestatic liver disease","volume":"125","author":"Horsmans","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.013_bib141","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib142","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(73)90055-X","article-title":"Intravenous lignocaine for relief of intractable itch","volume":"1","author":"Watson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.013_bib143","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(93)90858-A","article-title":"Subhypnotic doses of propofol relieve pruritus associated with liver disease","volume":"104","author":"Borgeat","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.013_bib144","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00000542-199204000-00004","article-title":"Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal morphine","volume":"76","author":"Borgeat","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cld.2008.02.013_bib145","first-page":"672","article-title":"Propofol and cholestatic pruritus","volume":"87","author":"Borgeat","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.013_bib146","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjmed.2005.05.031","article-title":"Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases","volume":"118","author":"Villamil","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2008.02.013_bib147","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2004.01.019","article-title":"Histamine-induced Ca(2+) influx via the PLA(2)\/lipoxygenase\/TRPV1 pathway in rat sensory neurons","volume":"361","author":"Kim","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cld.2008.02.013_bib148","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1523\/JNEUROSCI.4643-06.2007","article-title":"TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase","volume":"27","author":"Shim","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.cld.2008.02.013_bib149","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nature06191","article-title":"Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers","volume":"449","author":"Binshtok","year":"2007","journal-title":"Nature"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T06:46:36Z","timestamp":1684392396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1089326108000299"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.02.013","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}